Senhwa Biosciences, Inc. (6492.TWO)
TWD 35.1
(-9.88%)
TWD 35.1
(-9.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -10.17 Million TWD | -53.97% |
| 2022 | -6.6 Million TWD | -11.77% |
| 2021 | -5.91 Million TWD | 12.56% |
| 2020 | -6.76 Million TWD | 16.78% |
| 2019 | -8.12 Million TWD | -195.27% |
| 2018 | -2.75 Million TWD | -36.39% |
| 2017 | -2.01 Million TWD | -67.25% |
| 2016 | -1.2 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -2.89 Million TWD | 104.98% |
| 2024 Q1 | -2.83 Million TWD | -4.04% |
| 2023 Q3 | -2.64 Million TWD | -1.73% |
| 2023 Q1 | -2.2 Million TWD | -6.07% |
| 2023 Q2 | -2.6 Million TWD | -18.07% |
| 2023 Q4 | -2.72 Million TWD | -2.91% |
| 2023 FY | -10.17 Million TWD | -53.97% |
| 2022 Q2 | -1.31 Million TWD | 2.88% |
| 2022 FY | -6.6 Million TWD | -11.77% |
| 2022 Q4 | -2.07 Million TWD | -11.73% |
| 2022 Q3 | -1.85 Million TWD | -41.26% |
| 2022 Q1 | -1.35 Million TWD | 2.87% |
| 2021 FY | -5.91 Million TWD | 12.56% |
| 2021 Q4 | -1.39 Million TWD | 9.53% |
| 2021 Q3 | -1.54 Million TWD | 0.0% |
| 2020 FY | -6.76 Million TWD | 16.78% |
| 2019 FY | -8.12 Million TWD | -195.27% |
| 2018 FY | -2.75 Million TWD | -36.39% |
| 2017 FY | -2.01 Million TWD | -67.25% |
| 2016 FY | -1.2 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | 3192.097% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 102.527% |
| Level Biotechnology Inc. | 219.54 Million TWD | 104.634% |
| Sagittarius Life Science Corp | 71.47 Million TWD | 114.233% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | -11.976% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 104.517% |
| GlycoNex Incorporation | 995 Thousand TWD | 1122.412% |
| VBI | 16.42 Million TWD | 161.944% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | 136.88% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 105.126% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | 2052.591% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 108.484% |
| Visgeneer Inc. | 67.48 Million TWD | 115.075% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 97.289% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 100.724% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 107.036% |
| Neith Corporation | 18.01 Million TWD | 156.457% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 104.419% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 144.732% |
| Enimmune corporation | -23.37 Million TWD | 56.475% |
| TaiRx, Inc. | 2.43 Million TWD | 517.097% |
| CHO Pharma, Inc. | -28.27 Million TWD | 64.026% |
| EirGenix Inc. | 236.74 Million TWD | 104.297% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 109.749% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 103.563% |
| Lin BioScience, Inc. | -17.92 Million TWD | 43.253% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 111.352% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 112.603% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | 1039.335% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 107.598% |
| RBC Bioscience Corporation | 72.89 Million TWD | 113.956% |
| BiOptic Inc. | 152.74 Million TWD | 106.66% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | 11403.333% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 252.587% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 489.025% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 101.58% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 15.239% |
| NaviFUS Corp. | 11.82 Million TWD | 186.015% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 110.512% |
| Sinew Pharma Inc. | -28.98 Million TWD | 64.903% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | 3350.16% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 102.592% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 124.524% |
| AP Biosciences Inc | 32.25 Million TWD | 131.541% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 101.648% |
| 3D Global Biotech Inc. | 5.27 Million TWD | 292.89% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 103.235% |
| Intech Biopharm Corporation | -163.99 Million TWD | 93.797% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | 131.242% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | -152.494% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | -4.456% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 102.099% |
| TCI GENE Inc. | 174.61 Million TWD | 105.826% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 38.721% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 113.323% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 113.218% |
| PharmaEngine, Inc. | 718.97 Million TWD | 101.415% |
| Savior Lifetec Corporation | 220.94 Million TWD | 104.604% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 109.109% |
| OBI Pharma, Inc. | -73.49 Million TWD | 86.159% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 107.326% |
| Acepodia, Inc. | 16.59 Million TWD | 161.309% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 137.034% |